Cell genomics

made easy

Services

We care for your cells

Stem Genomics provides specific services to assess the genetic integrity of stem cells. We offer a range of new tests that use droplet digital PCR and a panel of specific probes to detect most of the recurrent genetic abnormalities observed in stem cells. This innovation, called iCS-digital (in Culture Supernatant digital PCR), is rapid, robust, and cost-effective, and can be performed on cell culture supernatants.

The gene Editing-digital PCR (Ed-digital) test directly informs on the presence and number of transgenes inserted in the genome of CRISPR-edited cells.

About

Stem Genomics

Stem Genomics develops a technology invented by Prof John De Vos and Dr Said Assou, researchers at the Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, and co-founders of the company. Located at the heart of the University Hospital Centre of Montpellier, IRMB houses research groups working on basic stem cell research and on innovative applications for regenerative therapy, with the aim of facilitating the transfer from research to clinical applications. Stem Genomics is located at the IRMB Cyborg business incubator and works in close collaboration with IRMB researchers. Stem Genomics has emerged from a prestigious scientific environment.

References

They trust us

Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
https://bioneer.dk/
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
https://www.bcm.edu/research/advanced-technology-core-labs/lab-listing/human-stem-cell-core
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics
Reference Stem Genomics

Latest news

discover and share

The iCS-digital test now published  in Stem Cell Reports
Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR In the article published in Stem Cell Reports in January 2020, Assou et al. demonstrate the interest of the iCS-digital TM test for routine human pluripotent stem cell (hPSC) screening. Thanks to the specificity of the droplet digital PCR (ddPCR) probe panel, the simplicity of sample collection, and the accuracy of the ddPCR technology, this test allows the fast and straightforward monitoring of hPSC integrity. This innovative test can change how hPSC quality controls are implemented for basic research and cell therapy by increasing the test frequency to secure cell productions and avoid expensive and time-consuming cell cultures. The iCS-digital TM test is exclusively provided by Stem Genomics as a full service. To request technical information or ask for a quote, please follow this link : Link to the publication Discover the test and request a quote